0001213900-20-029372.txt : 20200930 0001213900-20-029372.hdr.sgml : 20200930 20200930210018 ACCESSION NUMBER: 0001213900-20-029372 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200929 FILED AS OF DATE: 20200930 DATE AS OF CHANGE: 20200930 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McWilliams David CENTRAL INDEX KEY: 0001303311 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39555 FILM NUMBER: 201214020 MAIL ADDRESS: STREET 1: 2575 WEST BELLFORT STREET CITY: HOUSTON STATE: TX ZIP: 77054-9816 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Greenwich LifeSciences, Inc. CENTRAL INDEX KEY: 0001799788 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205473709 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3992 BLUEBONNET DR, BUILDING 14 CITY: STAFFORD STATE: TX ZIP: 77477 BUSINESS PHONE: 203-434-3290 MAIL ADDRESS: STREET 1: 3992 BLUEBONNET DR, BUILDING 14 CITY: STAFFORD STATE: TX ZIP: 77477 4 1 ownership.xml X0306 4 2020-09-29 0 0001799788 Greenwich LifeSciences, Inc. GLSI 0001303311 McWilliams David C/O GREENWICH LIFESCIENCES, INC. 3992 BLUEBONNET DR., BUILDING 14 STAFFORD TX 77477 1 0 0 0 Common Stock 2020-09-29 4 M 0 152604 A 599583 D Common Stock 2020-09-29 4 M 0 7663 A 607246 D Common Stock 2020-09-29 4 M 0 3746 A 610992 D Common Stock 2020-09-29 4 M 0 7609 A 618601 D Series A Preferred Stock 2020-09-29 4 M 0 152604 0 D Common Stock 152604 0 D Series B Preferred Stock 2020-09-29 4 M 0 7663 0 D Common Stock 7663 0 D Series C Preferred Stock 2020-09-29 4 M 0 3746 0 D Common Stock 3746 0 D Series D Preferred Stock 2020-09-29 4 M 0 6555 0 D Common Stock 6555 0 D Series D Preferred Stock 2020-09-29 4 J 0 1054 0 A Common Stock 1054 1054 D Series D Preferred Stock 2020-09-29 4 M 0 1054 0 D Common Stock 1054 0 D The Series A Preferred Stock converted into Issuer common stock on a 1-for-1 basis and had no expiration date. The Series B Preferred Stock converted into Issuer common stock on a 1-for-1 basis and had no expiration date. The Series C Preferred Stock converted into Issuer common stock on a 1-for-1 basis and had no expiration date. The Series D Preferred Stock converted into Issuer common stock on a 1-for-1 basis and had no expiration date. The Series D Preferred Stock have no expiration date and are convertible, at the option of the holder, into shares of common stock of the Issuer at the then-effective conversion rate for no additional consideration (subject to the payment of cash, if applicable, in lieu of any fractional shares in accordance with the Issuer's Amended and Restated Certificate of Incorporation, as amended (the "Certificate of Incorporation"). The Reporting Person was issued additional shares of Series D Preferred Stock in connection with the Issuer's initial public offering as a result of the anti-dilution protection provisions set forth in the Issuer's Certificate of Incorporation. /s/ David McWilliams 2020-09-30